Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
British Journal of Haematology
|
March 4, 2006
Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease
Itai Magal, Ehud Lebel, Gheona Altarescu, et al.
Rheumatology International
|
March 5, 2008
Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density
Efrat Arnheim, Gaya Chicco, Mici Phillips, et al.
Menopause (New York, N.Y.)
|
June 6, 2007
Effects of estradiol and raloxifene on arterial thrombosis in ovariectomized mice
Rami Abu-Fanne, Amnon Brzezinski, Mordechai Golomb, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial
Jacques P Brown, Klaus Engelke, Tony M Keaveny, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
British Journal of Haematology
|
March 4, 2006
Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease
Itai Magal, Ehud Lebel, Gheona Altarescu, et al.
Rheumatology International
|
March 5, 2008
Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density
Efrat Arnheim, Gaya Chicco, Mici Phillips, et al.
Menopause (New York, N.Y.)
|
June 6, 2007
Effects of estradiol and raloxifene on arterial thrombosis in ovariectomized mice
Rami Abu-Fanne, Amnon Brzezinski, Mordechai Golomb, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial
Jacques P Brown, Klaus Engelke, Tony M Keaveny, et al.
Page
of 2